Our aim was to determine whether in vitro studies would detect differences in the cellular response to wear particles of two titanium alloys commonly used in the manufacture of joint replacement prostheses. Particles were of the order of 1 m in diameter representative of those found adjacent to failed prostheses.
Wear particles from endoprostheses provoke the release of inflammatory mediators from macrophages which may differ according to the material used. This may influence the extent of periprosthetic bone loss. The wear of titaniumalloy prostheses, including the articulating surfaces, the surfaces of the modular components, and cemented and cementless femoral stems, results in the accumulation of wear particles in the periprosthetic tissues. [1] [2] [3] Despite this, titanium alloys are useful implant materials because of their excellent mechanical properties, their resistance to corrosion, and apparent biocompatibility in solid form. 3 There has been concern, however, regarding one of the commonly used alloys, titanium 6-aluminium 4-vanadium alloy (TiAlV), because of the potential adverse effects of vanadium. 4, 5 An alternative titanium alloy, titanium 6-aluminium 7-niobium (TiAlNb), was therefore developed with comparable mechanical properties to those of high-strength TiAlV and with more resistance to corrosion at low pH. [6] [7] [8] TiAlV particles are known to stimulate a macrophage response in vivo and provoke the release of inflammatory mediators from these cells in vitro. [9] [10] [11] [12] TiAlNb particles are likely to have similar effects but they may be less marked because of the different metals in TiAlNb or because of its enhanced corrosion resistance. No differences have been reported, however, in the cellular response in vivo to these alloys in solid form 13 and only small differences in the number and types of cells in the tissues after injection of particles of both alloys. 14 This may suggest that the cellular responses are similar, but the in vivo tests are relatively insensitive and important biological differences may not have been detected. Our aim was to determine if in vitro studies could detect differences in the cellular responses to wear particles of TiAlV and TiAlNb, by measuring the release of prostaglandin E 2 (PGE 2 ) from human monocytes. PGE 2 was considered important because it is present in periprosthetic tissue retrieved at revision surgery for loosening and has been proposed as a factor in periprosthetic bone resorption. [15] [16] [17] It is also known to be released in vitro in response to TiAlV. 11 Other mediators of bone resorption, such as interleukin-1␤ (IL-1), tumour necrosis factor ␣ (TNF) and interleukin-6 (IL-6), have been identified in periprosthetic tissue and implicated in the inflammatory response to wear particles and periprosthetic loosening. [18] [19] [20] [21] [22] We therefore also examined differences in the release of these mediators as well as cytotoxicity. Because previous in vitro studies have shown that commercially-pure titanium (cpTi) particles induce the release of fewer bone-resorbing mediators than TiAlV particles, 12 we also compared the response to cpTi particles with that to TiAlV and TiAlNb.
MATERIALS AND METHODS
Generation of wear particles. Three separate preparations of wear particles were produced: TiAlV (Protasul 64), TiAlNb (Protasul 100), and cpTi. Hemispherical cups with an internal diameter of 44 mm and blocks measuring 4 ϫ 4 ϫ 1 mm for each material were provided by Dr W. Frick (Protek AG, Berne, Switzerland) and were prepared using the same manufacturing standards as for human implants. The components were soaked overnight in a 0.1% solution of E-Toxa-Clean (Sigma Chemical Co, St Louis, Missouri) and rinsed three times in endotoxin-free deionised water. They were then soaked for 20 minutes in 20% nitric acid in accordance with ASTM F86-76 standard recommended practice for surface preparation and marking of metallic surgical implants. 23 The rinsing was repeated three times and the components were sterilised by dry heating at 180°C overnight. Wear particles were produced by the shaking of a chamber as has been described previously. 24 The hemispherical cups containing blocks of the same titanium material and a shaking solution were sealed and shaken with phosphate-buffered saline supplemented with 2% fetal calf serum (FCS), 5 g/ ml penicillin and 50 U/ml streptomycin for 72 hours. After discarding the first suspension, subsequent particle suspensions after each 72-hour period were stored at 0°C. Attention was given to producing particles free from endotoxin contamination. All washing and preparation steps were carried out in thoroughly clean, heat-sterilised glassware. Low-endotoxin FCS was purchased in bulk (Commonwealth Serum Laboratories Ltd, Parkville, Australia). Levels of endotoxin were monitored regularly throughout the period of particle generation using the Limulus amoebocyte lysate test. Levels were below 10 pg per ml.
The particle suspensions generated for each of the titanium materials were sized separately by differential centrifugation to obtain particles in the range 0.5 to 3.0 m.
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The size distribution was confirmed using a Coulter counter (Multisizer 2; Coulter Electronics, Luton, UK). The shape of the distribution graphs for each material was similar and the mode values for TiAlV, TiAlNb and cpTi were 0.62, 0.66 and 0.66 m, respectively. The concentration of metal in each suspension was determined by mass spectrometry (VG Plasmaquad PQ2 Plus, VG Isotopes, Winsford, UK) and the concentration as particles per ml was calculated using the total titanium-alloy metal content (g/ml), the density of each alloy, and the mode value for particle diameter. 24 Three suspensions of each particle were prepared by vigorous sonication followed by dilution in RPMI 1640 medium containing 10% FCS, 5 g/ml penicillin and 50 U/ml streptomycin, 2 mM L-glutamine and 50 M ␤-mercaptoethanol. The suspensions contained 4 ϫ 10 7 , 1 ϫ 10 7 and 2.5 ϫ 10 6 particles per ml and were designated respectively as high, medium and low concentrations. As previous studies have shown a large increase in PGE 2 release by macrophages after exposure to TiAlV particles at a concentration of 4 ϫ 10 7 particles per ml this was chosen as a high dose 11 and corresponds to 57.6 g/ml.
Measurement of particle dimension. We used transmission electron microscopy to measure particle dimensions and to detect shape differences between the titanium preparations. 24 The greatest length and breadth of a particle were measured from photomicrographs. We measured 100 particles in each sample. The different titanium preparations were analysed using Student's t-test with p р 0.025 being taken as significant. The length and breadth of the individual particles were not significantly different (Table I) .
Isolation and culture of cells. We collected human peripheral blood monocytes from eight healthy volunteer donors and isolated them by Ficoll-hypaque sedimentation and adherence to glass. 25 A suspension of 500 l of 4 ϫ 10 6 cells/ml from each donor was pipetted onto ethanol-washed glass coverslips in a 24-well Linbro plate. The monocytes were allowed to adhere at 37°C in a humidified 5% CO 2 atmosphere. After one hour, the coverslips were washed three times by gentle shaking with Hanks' balanced salt solution. Non-specific esterase staining established that the remaining adherent cells were greater than 96% pure monocytes. Particle suspensions were added to the cells along with appropriate volumes of media to ensure a final volume of 500 l for each well and each was tested in duplicate. Lipopolysaccharide (LPS) 5 g/ml (Escherichia coli 0111:B4; Sigma Chemical, St Louis, Missouri) was used as a positive control for mediator release. Cells cultured in media alone were used as a negative control (nonstimulated cells). The cells were cultured for 48 hours. The supernatants were removed and were centrifuged to remove metal particles. The resultant aliquoted supernatants were either tested immediately for levels of mediators or stored at -70°C until ready for testing. Analysis of mediator release. We determined levels of PGE 2 using a competitive radioimmunoassay. 26 Levels of IL-1, TNF and IL-6 were measured by enzyme-linked immunoassays (Cayman Chemical Co, Ann Arbor, Michigan and MedGenix Diagnostics, Fleurus, Belgium). The To determine the patterns of release of all the mediators in response to the three titanium materials, the level of mediator release was compared with that from non-stimulated cells. Statistical significance was calculated using the paired Student's t-test. Because there was considerable variation between the monocyte response to each donor, the results were also expressed as a percentage of the nonstimulated cells; the level of mediator release by nonstimulated cells was taken to be 100% and the mean percentage change for each treatment was calculated. To determine the variation in mediator release due to errors in measurement techniques, IL-6 release from a single batch of cells from one donor was measured ten times. The mean IL-6 release after exposure of the cells to high concentrations of TiAlV, TiAlNb, cpTi particles and of non-stimulated cells was 996 ± 99, 401 ± 62, 399 ± 32 and 208 ± 45 pg/ml, respectively. Cell viability. Cell viability was assessed by trypan blue exclusion. 27 
RESULTS
We found an increased release of all the mediators after exposure to TiAlV particles compared with TiAlNb and cpTi particles. The mean PGE 2 release in response to highconcentration TiAlV particles was 2627.6 ± 846.6 pM and to TiAlNb particles 317.4 ± 140.6 pM (p = 0.006). Highconcentration TiAlV particles stimulated release of PGE 2 levels 15 times higher than that from non-stimulated cells (p = 0.005) while high-concentration TiAlNb particles gave approximately a twofold increase (p = 0.05) as did cpTi particles (p = 0.02) (Fig. 1) . Lower concentrations caused little or no increase in PGE 2 release.
A similar pattern was observed with IL-1 release (Fig.  2) . High-concentration TiAlV particles stimulated fivefold higher IL-1 release than that from non-stimulated cells (p = 0.005), while high-concentration TiAlNb particles induced a twofold increase in IL-1 release (p = 0.04) as did cpTi particles (p = 0.01). As with PGE 2 , IL-1 release was unremarkable after exposure to lower concentrations of any of the titanium preparations.
As regards TNF, high-concentration TiAlV particles stimulated release 15 times higher than that from nonstimulated cells (p = 0.002) (Fig. 3) and medium-concentration TiAlV particles induced a smaller threefold increase in release (p = 0.002). High concentrations of TiAlNb particles induced a threefold increase (p = 0.001) as did cpTi (p = 0.001), whereas medium concentrations produced a twofold increase (p = 0.002) as did cpT1 particles (p = 0.02). TNF release induced by the low concentration of any of the particles was unremarkable.
High concentrations of TiAlV particles stimulated a fivefold higher release of IL-6 than that from non-stimulated cells (p = 0.002) (Fig. 4) . Medium-concentration TiAlV particles induced a twofold increase (p = 0.06). High-concentration TiAlNb particles and cpTi particles produced a twofold increase in IL-6 release (p = 0.06 and p = 0.01, respectively). After exposure to lower concentrations IL-6 release was unremarkable.
When the results were analysed according to the percentage change in mediator release relative to non-stimulated cells similar differences in mediator release were seen.
Examination of the cultures using phase-contrast microscopy showed no difference in the morphology of the cells, in the phagocytosis of particles of all three materials or in the amount of phagocytosis among the different materials. Particles were relatively non-toxic to the cells. The proportions of viable cells exposed to high concentrations of TiAlV, TiAlNb and cpTi particles were 98 ± 2%, 98 ± 1% The release of PGE 2 by human monocytes in response to titanium particles (*p < 0.05; **p < 0.005). Fig. 2 The release of IL-1 by human monocytes in response to titanium particles (*p < 0.05; **p < 0.005). and 96 ± 3%, respectively compared with 97 ± 3% from non-stimulated cells.
DISCUSSION
Our study has shown in vitro differences in cellular responses to wear particles generated from different titanium materials. The large increase in PGE 2 release in response to TiAlV compared with TiAlNb confirmed our hypothesis, and the finding of a much greater release of all the other inflammatory cytokines in response to TiAlV compared with TiAlNb and cpTi supports the view that TiAlV causes greater stimulation of phagocytic cells than the other two materials.
Previous in vitro studies have shown that TiAlV particles stimulate the release of PGE 2 , IL-1, TNF and IL-6 from human peripheral blood monocytes and rodent peritoneal macrophages. [9] [10] [11] [12] This stimulatory effect was shown to be slightly less when human monocytes were exposed to cpTi particles. 12 Our data support these findings and in addition we have shown that release of these mediators was less with TiAlNb than with TiAlV. We selected human peripheral blood monocytes as the target cells since they are precursors of tissue macrophages which have consistently been identified in association with wear particles in periprosthetic tissues 28 and are known to produce potent inflammatory and bone-resorbing mediators. Previous studies have shown an inflammatory response to TiAlV by rodent peritoneal macrophages, 11 but we felt that it was important to use human cells because the pattern of response to particulate may vary according to the type of phagocytic cell 29 and because we were specifically addressing the differences in response to biomaterials in clinical use. The levels of mediator release varied considerably among the eight donors. Some of this variation was shown to be due to errors in measurement techniques, but most was attributed to differences in response between donors. The pattern of response, however, was similar for all eight donors.
These results differ from in vivo studies which showed either no 13 or only slight differences 14 in the cellular responses to TiAlV, TiAlNb and cpTi. These studies, however, may have lacked the sensitivity necessary to detect differences in response to these materials since it is often difficult to make quantitative assessments of the response to biomaterials in vivo. In our study the wear particles of each material were of comparable size to those found in vivo. 28, [30] [31] [32] [33] Recent studies on how wear particles induce a macrophage response in vitro have highlighted the effect of low pH within the phagosome. 35 This was shown to be directly related to stimulation of mediator release by the macrophage. TiAlNb is as corrosion-resistant as commercially pure titanium and is more corrosion-resistant than TiAlV. 36 TiAlNb alloy is less susceptible to corrosion at low pH than TiAlV alloy 6, 8 which may explain the significant differences in cellular response observed between them. Other wear particles, such as those of cobalt-chrome alloy, are susceptible to intracellular corrosion, but produce more toxic effects 35, 37 while causing less release of mediators than TiAlV.
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Our study has shown that human monocytes in vitro release significantly more bone-resorbing mediators after exposure to particles of TiAlV compared with TiAlNb. While the results of in vitro studies should not be directly transposed to the human situation, we postulate that if there are differences in release of bone-resorbing mediators in human periprosthetic tissues then TiAlV wear particles may cause more osteolysis than TiAlNb particles.
We wish to thank Professor Barrie Vernon-Roberts for his advice and support, and Zophia Krzemionka for her advice on preparation of the The release of TNF by human monocytes in response to titanium particles (*p < 0.05; **p < 0.005). The release of IL-6 by human monocytes in response to titanium particles (*p < 0.05; **p < 0.005).
manuscript. This work was supported in part by research grants from Protek AG, Berne, Switzerland, and the National Health and Medical Research Council of Australia. One or more of the authors have received or will receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this article. In addition benefits have also been or will be directed to a research fund, foundation, educational institution, or other non-profit institution with which one or more of the authors is associated.
